Featured Firms
Presented by BigVoodoo
In the second day of the Chiron Corp. v. Genentech Inc. patent trial, attorneys continued to lecture jurors about monoclonal antibodies, antigens and the U.S. patent system. While jurors will have to wade through such arcane data in deciding who invented the technology underlying Genentech's Herceptin breast cancer drug, Chiron's attorney suggested there's an easier way: Just follow the decisions of the U.S. Patent and Trademark Office.
August 08, 2002 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS